In conjunction with our alliance partners, Marinova can develop and produce pharmaceutical and reference grade fucoidan extracts. Our expertise in the chemistry and functionality of sulphated polysaccharides allows us to collaborate with international biotechnology and pharmaceutical companies to isolate discrete fucoidan compounds for specific biomedical applications. The isolation of distinct fractions can be based upon a variety of physical and chemical properties. Molecular weight can be altered and a specific profile assigned to each particular product allowing for key variables such as sulphation and acetylation to be controlled. Marinova has developed qualified analytical methodologies for the production of depyrogenated fucoidan fractions which satisfy FDA and European regulatory requirements. We stand alone in our ability to work with pharmaceutical companies to create highly purified fucoidan derivatives with defined biological activities.

For a comprehensive explanation of the bioactivity of fucoidans and their potential in pharmaceutical applications please click here.